ProMIS Neurosciences
PMN
17 hedge funds and large institutions have $12.6M invested in ProMIS Neurosciences in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
157% more capital invested
Capital invested by funds: $4.9M → $12.6M (+$7.71M)
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
21% more funds holding
Funds holding: 14 → 17 (+3)
0.66% more ownership
Funds ownership: 0.69% → 1.35% (+0.66%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.17M |
| 2 |
AC
Armistice Capital
New York
|
+$3.99M |
| 3 |
ACM
Altium Capital Management
New York
|
+$868K |
| 4 |
ABG
Ally Bridge Group
New York
|
+$796K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$172K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAA
Affinity Asset Advisors
New York
|
-$351K |
| 2 |
HC
Hara Capital
Bellevue,
Washington
|
-$44.1K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$30 |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$6 |
PMN Hedge Fund Activity: Q3 2024 in Review
17 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q3 2024, worth a combined $12.6M — up 157% from $4.9M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PMN positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Great Point Partners, opening a new position worth an estimated $4.17M. The largest seller was Affinity Asset Advisors, cutting an estimated $351K.
- 17 institutional investors held ProMIS Neurosciences (PMN) as of Q3 2024, up from 14 in Q2 2024.
- Funds reported $12.6M of ProMIS Neurosciences stock for Q3 2024, up 157% quarter-over-quarter.
- 5 funds opened new ProMIS Neurosciences positions in Q3 2024 and 2 closed out, a net change of +3 holders.
- The largest ProMIS Neurosciences buyer in Q3 2024 was Great Point Partners, an estimated $4.17M added.
- The largest ProMIS Neurosciences seller in Q3 2024 was Affinity Asset Advisors, an estimated $351K sold.
Based on aggregated 13F filings for Q3 2024.